lanreotide acetate
Generic: lanreotide acetate
Labeler: cipla usa inc.Drug Facts
Product Profile
Brand Name
lanreotide acetate
Generic Name
lanreotide acetate
Labeler
cipla usa inc.
Dosage Form
INJECTION
Routes
Active Ingredients
lanreotide acetate 60 mg/.2mL
Manufacturer
Identifiers & Regulatory
Product NDC
69097-880
Product ID
69097-880_fd205110-15eb-4707-82b2-185e5bbf616b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA215395
Listing Expiration
2026-12-31
Marketing Start
2021-12-24
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69097880
Hyphenated Format
69097-880
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lanreotide acetate (source: ndc)
Generic Name
lanreotide acetate (source: ndc)
Application Number
NDA215395 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 60 mg/.2mL
Packaging
- 1 SYRINGE in 1 CARTON (69097-880-67) / .2 mL in 1 SYRINGE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "fd205110-15eb-4707-82b2-185e5bbf616b", "openfda": {"unii": ["IEU56G3J9C"], "rxcui": ["749811", "749814", "749817"], "spl_set_id": ["11da176a-99bc-4ada-8b3f-6bd2b37a6313"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (69097-880-67) / .2 mL in 1 SYRINGE", "package_ndc": "69097-880-67", "marketing_start_date": "20211224"}], "brand_name": "Lanreotide Acetate", "product_id": "69097-880_fd205110-15eb-4707-82b2-185e5bbf616b", "dosage_form": "INJECTION", "pharm_class": ["Somatostatin Analog [EPC]", "Somatostatin Receptor Agonists [MoA]"], "product_ndc": "69097-880", "generic_name": "lanreotide acetate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lanreotide Acetate", "active_ingredients": [{"name": "LANREOTIDE ACETATE", "strength": "60 mg/.2mL"}], "application_number": "NDA215395", "marketing_category": "NDA", "marketing_start_date": "20211224", "listing_expiration_date": "20261231"}